Antibiotic Resistance Research Report 2024: 6 Key Large Opportunities in this Space and Developed Market Forecasts with Profiles of 100+ Biotechnology Companies
October 15, 2024 10:31 ET
|
Research and Markets
Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...
Impetigo Drugs Global Strategic Business Report 2024 - Fusidane Drug Segment is Expected to Reach US$883.5 Million by 2030, with a CAGR of a 5.1%
September 02, 2024 05:59 ET
|
Research and Markets
Dublin, Sept. 02, 2024 (GLOBE NEWSWIRE) -- The "Impetigo Drugs - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Impetigo Drugs was...
Antibiotics Strategic Business Report 2024: Rising Demand in Emerging Economies Accelerates Demand, Narrow-Spectrum Antibiotics Spurs Innovation in Targeted Therapy - Forecast to 2030
August 01, 2024 09:40 ET
|
Research and Markets
Dublin, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The "Antibiotics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Antibiotics is...
Antibacterial Drugs Research - Global Strategic Business Report to 2030 Featuring Allergan, AstraZeneca, Bayer, BMS, GSK, Johnson & Johnson, Merck, Novartis, Pfizer,
July 26, 2024 06:27 ET
|
Research and Markets
Dublin, July 26, 2024 (GLOBE NEWSWIRE) -- The "Antibacterial Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Antibacterial...
Antibiotic Resistance Markets Therapeutics, by Pathogen and Therapy Type to 2027: Search for Alternatives to Antibiotics Creates New Global Goldrush
May 27, 2024 03:01 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides & Customization....
Global Antibiotic Drugs Market Research Report 2024: Cephalosporin, Penicillin, Macrolides, Fluoroquinolone, Others Insights and Forecasts, 2019-2029
February 27, 2024 10:22 ET
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Global Antibiotic Drugs Market (2024 Edition): Analysis By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoroquinolone, Others), Spectrum...
Glycopeptide Antibiotics Global Market Report 2024: Forecast to Reach $5.02 Billion by 2028 - Long-term Forecast to 2028 and 2033
January 25, 2024 04:19 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Glycopeptide Antibiotics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global glycopeptide antibiotics...
Antimicrobial Resistance Surveillance Market: Projected Growth at 5.6% CAGR Through 2028
January 23, 2024 06:13 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Surveillance Market by Solution (Kits, System, Surveillance Software, Service), Application (Clinical Diagnostics, Public...
Global Pseudomonas Aeruginosa Infection Treatment Market Report 2024: A USD 4.07 Billion Market by 2034, with Novel Antibiotics and Combination Therapies Emerging
January 22, 2024 05:18 ET
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Pseudomonas Aeruginosa Infection Treatment Market" report has been added to ResearchAndMarkets.com's offering. The global pseudomonas...
Global Antibiotic Resistance Markets, 2023-2027: Beyond Antibiotics - Exploring Cutting-Edge Trends in AMR Solutions
October 05, 2023 06:43 ET
|
Research and Markets
Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...